Our study confirmed that 75 and 67.7% pediatric B-ALL bone marrow blasts were CD123 positive (>20%) in the CCLG-ALL-2008 and CCCG-ALL-2015 cohorts, respectively. The gene discussed is IL3RA; the disease is precursor B-cell acute lymphoblastic leukemia.